Pediatric Hematology/Oncology

Cancer-related Side Effects

Questions discussed in this category

How do you manage severe hypertriglyceridemia in the adolescent & young adult population receiving chemotherapy for ALL, in the absence of complications related to hypertriglyceridemia?

1 Answer available

In a patient with HR B ALL and severe pancreatitis due to peg-asparaginase, how do you assess the impact of peg discontinuation on risk of relapse?

For patients not on study, would you consider replacing missed doses of peg with a non-asparaginase based chemotherapy?

2 Answers available

How do you manage cancer treatment-related cognitive change or "chemo brain?"

Are there any effective non-pharm or pharm interventions?

1 Answer available

Papers discussed in this category

EMBO Mol Med, 2020 Apr 29

Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.

J Oncol, 2020 Jun 24

Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review.

The Lancet. Oncology, 2017-09

Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.

J Clin Oncol, 2020 Apr 10

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Related Topics in Pediatric Hematology/Oncology